Basics Of Chimeric Antigen Receptor Car Immunotherapy
Download Basics Of Chimeric Antigen Receptor Car Immunotherapy full books in PDF, epub, and Kindle. Read online free Basics Of Chimeric Antigen Receptor Car Immunotherapy ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: Daniel W. Lee |
Publisher |
: Elsevier Health Sciences |
Total Pages |
: 246 |
Release |
: 2019-11-30 |
ISBN-10 |
: 9780323755979 |
ISBN-13 |
: 0323755976 |
Rating |
: 4/5 (79 Downloads) |
Synopsis Chimeric Antigen Receptor T-Cell Therapies for Cancer E-Book by : Daniel W. Lee
From patient referral to post-therapy management, Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer: A Practical Guide presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area. - Covers all clinical aspects, including patient referral, toxicities management, comorbidities, bridging therapy, post-CAR monitoring, and multidisciplinary approaches to supportive care. - Includes key topics on associated toxicities such as predictive biomarkers, infections, and multidisciplinary approaches to supportive care. - Presents current knowledge on FDA approved CAR T-cell products as well as developments on the horizon. - Editors and authors represent leading investigators in academia and worldwide pioneers of CAR therapy.
Author |
: Mumtaz Y. Balkhi |
Publisher |
: Academic Press |
Total Pages |
: 92 |
Release |
: 2019-07-31 |
ISBN-10 |
: 9780128197479 |
ISBN-13 |
: 0128197471 |
Rating |
: 4/5 (79 Downloads) |
Synopsis Basics of Chimeric Antigen Receptor (CAR) Immunotherapy by : Mumtaz Y. Balkhi
Basics of Chimeric Antigen Receptor (CAR) Immunotherapy presents the latest on how T cell adoptive immunotherapy has progressed in its ultimate goal of curing metastatic malignant cancers. Recent clinical data obtained with checkpoint receptor blockade inhibitors and chimeric antigen receptor (CAR) therapy has been especially promising, thus generating renewed hope that we may be on the verge of finally curing cancer. Over the years, huge progress has been made in controlling several stage IV metastasized cancers through the clinical application of checkpoint receptor inhibitory drugs and CAR-Therapy that has seen unprecedented interest in the immunotherapy field. Presents the first book to provide a basic understanding of chimeric antigen receptor (CARs) design, production and clinical application protocols Provides unique authority as the editor has worked directly with CARs Discusses the challenges encountered in actual clinical trials and how these challenges can be overcome Includes a full chapter on various challenges researchers should expect to encounter in the CAR-therapy field
Author |
: Nicolaus Kröger |
Publisher |
: Springer Nature |
Total Pages |
: 221 |
Release |
: 2022-02-07 |
ISBN-10 |
: 9783030943530 |
ISBN-13 |
: 3030943534 |
Rating |
: 4/5 (30 Downloads) |
Synopsis The EBMT/EHA CAR-T Cell Handbook by : Nicolaus Kröger
This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA), covers several aspects of CAR-T cell treatments, including the underlying biology, indications, management of side-effects, access and manufacturing issues. This book, written by leading experts in the field to enhance readers’ knowledge and practice skills, provides an unparalleled overview of the CAR-T cell technology and its application in clinical care, to enhance readers’ knowledge and practice skills.
Author |
: Kamilla Swiech |
Publisher |
: Humana |
Total Pages |
: 0 |
Release |
: 2019-11-10 |
ISBN-10 |
: 1071601458 |
ISBN-13 |
: 9781071601457 |
Rating |
: 4/5 (58 Downloads) |
Synopsis Chimeric Antigen Receptor T Cells by : Kamilla Swiech
This volume provides comprehensive methods from expert scientists working in the Chimeric Antigen Receptor T Cell (CAR-T Cell) field. Chapters guide readers through the state-of-art of CAR-T cell technology, CAR design and vector production, CAR-T cell generation and manufacturing, CAR-T cell characterization, and quality control. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Chimeric Antigen Receptor T Cells: Development and Production aims to be useful in the production of CAR-T cells, especially for therapeutic purposes.
Author |
: Dr. Hakim Saboowala |
Publisher |
: Dr.Hakim Saboowala |
Total Pages |
: |
Release |
: 2020-05-04 |
ISBN-10 |
: |
ISBN-13 |
: |
Rating |
: 4/5 ( Downloads) |
Synopsis Part I- Understanding Cancer Immunotherapy: A brief Review. Part II - “What is Chimeric Antigen Receptor (CAR)T-Cell Therapy? An Emerging Cancer Treatment Modality. by : Dr. Hakim Saboowala
Part I- Understanding Cancer Immunotherapy: A brief Review. Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer. It uses substances made by the body or in a laboratory to improve or restore immune system function. Immunotherapy may work by: Stopping or slowing the growth of cancer cells Stopping cancer from spreading to other parts of the body Helping the immune system work better at destroying cancer cells There are several types of immunotherapy, including: Monoclonal antibodies and tumor-agnostic therapies Non-specific immunotherapies Oncolytic virus therapy T-cell therapy Cancer vaccines Part II- “What is Chimeric Antigen Receptor (CAR) T- Cell Therapy?” An Emerging Cancer Treatment Modality. Chimeric antigen receptor (CAR) T-cell therapy is an emerging cancer treatment modality in which the patients’ own immune cells are collected, genetically engineered to recognize a tumor-related target, expanded in vitro, and then reinfused to produce responses and prevent progression in a variety of malignancies (ie, adoptive cell transfer) Several types of adoptive cell transfer(ACT) are under investigation, but CAR T-cell therapy is the first to enter clinical practice. Like other technologies, CAR-T cell therapy has undergone a long development process in the past. Chimeric antigen receptor- (CAR-) T cell therapy is one of the most recent innovative immunotherapies and is rapidly evolving. At present, CAR-T cell therapy is developing rapidly, and many clinical trials have been established on a global scale, which has great commercial potential. I have endeavored to compile this E- Booklet into Two Parts i.e. Part I & Part II for better understanding of Chimeric antigen receptor (CAR) T-cell therapy, an emerging cancer treatment modality. In Part I, an effort has been made to describe Cancer Immunotherapy briefly whereas in Part II know about of CAR T-Cell Therapy-the first to enter clinical practice- has been embodied. Further it is attempted to describe toxicity of CAR-T cell therapy briefly and future development and opportunities for immunotherapy. …Dr. H. K. Saboowala. M.B.(Bom) .M.R.S.H.(London)
Author |
: Manzoor Ahmad Mir |
Publisher |
: Academic Press |
Total Pages |
: 320 |
Release |
: 2015-05-25 |
ISBN-10 |
: 9780128026755 |
ISBN-13 |
: 0128026758 |
Rating |
: 4/5 (55 Downloads) |
Synopsis Developing Costimulatory Molecules for Immunotherapy of Diseases by : Manzoor Ahmad Mir
Developing Costimulatory Molecules for Immunotherapy of Diseases highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy using either humanized antibodies against CD80, CD86, and other costimulatory molecules or CD28 fusinogenic proteins in the treatment of diseases, including allergies, asthma, rheumatoid arthritis, multiple sclerosis, lupus nephritis, severe psoriasis, vulgaris tuberculosis, thopoid, transplantation therapeutic, cancer, and inflammation. The text aims to provide the latest information on the complex roles and interactions within the CD28 and B7 costimulatory families, with the hope that targeting these families will yield new therapies for the treatment of inflammation, autoimmunity, transplantation, cancer, and other infectious diseases. - Highlights the novel concept of reverse costimulation and how it can be effectively exploited to develop immunotherapy - Provides the latest information on the complex roles and interactions within the CD28 and B7 costimulatory families - Targets new therapies for the treatment of inflammation, autoimmunity, transplantation, cancer, and other infectious diseases
Author |
: Daniel W. Lee |
Publisher |
: Elsevier Health Sciences |
Total Pages |
: 0 |
Release |
: 2019-12-02 |
ISBN-10 |
: 0323661815 |
ISBN-13 |
: 9780323661812 |
Rating |
: 4/5 (15 Downloads) |
Synopsis Chimeric Antigen Receptor T-Cell Therapies for Cancer by : Daniel W. Lee
From patient referral to post-therapy management, Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer: A Practical Guide presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area. Covers all clinical aspects, including patient referral, toxicities management, comorbidities, bridging therapy, post-CAR monitoring, and multidisciplinary approaches to supportive care. Includes key topics on associated toxicities such as predictive biomarkers, infections, and multidisciplinary approaches to supportive care. Presents current knowledge on FDA approved CAR T-cell products as well as developments on the horizon. Editors and authors represent leading investigators in academia and worldwide pioneers of CAR therapy.
Author |
: R.J. Buka |
Publisher |
: Karger Medical and Scientific Publishers |
Total Pages |
: 71 |
Release |
: 2021-01-26 |
ISBN-10 |
: 9783318067422 |
ISBN-13 |
: 3318067423 |
Rating |
: 4/5 (22 Downloads) |
Synopsis Fast Facts: CAR T-Cell Therapy by : R.J. Buka
Chimeric antigen receptor (CAR) T cells are genetically engineered immune cells that can seek out and destroy cancer cells. The results from their use in cancer immunotherapy have been very promising, but treatment is often associated with frequent, serious short-term toxicities. 'Fast Facts: CAR-T Therapy' explains what CAR T cells are and how they were developed, discusses the results of clinical trials and the management of toxicities, and outlines future improvements and applications. It is ideal reading for any healthcare professional wanting to know more about this exciting therapeutic field. Table of Contents: • CAR T cells • Clinical application • Practical aspects • Future directions
Author |
: Miguel-Angel Perales |
Publisher |
: Springer |
Total Pages |
: 286 |
Release |
: 2018-11-27 |
ISBN-10 |
: 9783319543680 |
ISBN-13 |
: 3319543687 |
Rating |
: 4/5 (80 Downloads) |
Synopsis Cell and Gene Therapies by : Miguel-Angel Perales
In this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and gene therapies with the aim of providing trainee and practicing hematologists, including hematopoietic transplant physicians, with information that is relevant to clinical practice and ongoing research. Each chapter focuses on a particular topic, and the concise text is supported by numerous working tables, algorithms, and figures. Whenever appropriate, guidance is provided regarding the availability of potentially high-impact clinical trials. The rapid evolution of cell and gene therapies is giving rise to numerous controversies that need to be carefully addressed. In meeting this challenge, this book will appeal to all residents, fellows, and faculty members responsible for the care of hematopoietic cell transplant patients. It will also offer a robust, engaging tool to aid vital activities in the daily work of every hematology and oncology trainee.
Author |
: Tim F. Greten |
Publisher |
: Springer |
Total Pages |
: 0 |
Release |
: 2018-08-22 |
ISBN-10 |
: 3319879111 |
ISBN-13 |
: 9783319879116 |
Rating |
: 4/5 (11 Downloads) |
Synopsis Immunotherapy of Hepatocellular Carcinoma by : Tim F. Greten
In this book we provide insights into liver – cancer and immunology. Experts in the field provide an overview over fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune based approaches in HCC, which gain increasing interest in the community due to first promising results obtained in early clinical trials. Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of the major risk factors for HCC, which represents a typical “inflammation-induced” cancer. Immune-based treatment approaches have revolutionized oncology in recent years. Various treatment strategies have received FDA approval including dendritic cell vaccination, for prostate cancer as well as immune checkpoint inhibition targeting the CTLA4 or the PD1/PDL1 axis in melanoma, lung, and kidney cancer. Additionally, cell based therapies (adoptive T cell therapy, CAR T cells and TCR transduced T cells) have demonstrated significant efficacy in patients with B cell malignancies and melanoma. Immune checkpoint inhibitors in particular have generated enormous excitement across the entire field of oncology, providing a significant benefit to a minority of patients.